IRIS Accounts Production v24.3.2.46 09781184 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false 70225 89871 87484 95530 95229 115176 62480 70225 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097811842023-09-30097811842024-09-30097811842023-10-012024-09-30097811842022-09-30097811842022-10-012023-09-30097811842023-09-3009781184ns15:EnglandWales2023-10-012024-09-3009781184ns14:PoundSterling2023-10-012024-09-3009781184ns10:Director12023-10-012024-09-3009781184ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009781184ns10:SmallEntities2023-10-012024-09-3009781184ns10:AuditExemptWithAccountantsReport2023-10-012024-09-3009781184ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3009781184ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3009781184ns10:FullAccounts2023-10-012024-09-3009781184ns10:Director2422023-09-3009781184ns10:Director2422022-09-3009781184ns10:Director2422023-10-012024-09-3009781184ns10:Director2422022-10-012023-09-3009781184ns10:Director2422024-09-3009781184ns10:Director2422023-09-3009781184ns10:Director22023-10-012024-09-3009781184ns10:RegisteredOffice2023-10-012024-09-3009781184ns5:CurrentFinancialInstruments2024-09-3009781184ns5:CurrentFinancialInstruments2023-09-3009781184ns5:Non-currentFinancialInstruments2024-09-3009781184ns5:Non-currentFinancialInstruments2023-09-3009781184ns5:ShareCapital2024-09-3009781184ns5:ShareCapital2023-09-3009781184ns5:RetainedEarningsAccumulatedLosses2024-09-3009781184ns5:RetainedEarningsAccumulatedLosses2023-09-3009781184ns5:ComputerEquipment2023-09-3009781184ns5:ComputerEquipment2023-10-012024-09-3009781184ns5:ComputerEquipment2024-09-3009781184ns5:ComputerEquipment2023-09-3009781184ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009781184ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30097811841ns10:Director12023-09-30097811841ns10:Director12022-09-30097811841ns10:Director12023-10-012024-09-30097811841ns10:Director12022-10-012023-09-30097811841ns10:Director12024-09-30097811841ns10:Director12023-09-30
REGISTERED NUMBER: 09781184 (England and Wales)






















Unaudited Financial Statements

for the Year Ended 30 September 2024

for

Peslocus Healthcare Limited

Peslocus Healthcare Limited (Registered number: 09781184)






Contents of the Financial Statements
for the year ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 6

Peslocus Healthcare Limited

Company Information
for the year ended 30 September 2024







DIRECTORS: Mr O Oyeleye
Mrs O Oyeleye





REGISTERED OFFICE: 5 Waltham Road
Boreham
Chelmsford
Essex
CM3 3AS





REGISTERED NUMBER: 09781184 (England and Wales)





ACCOUNTANTS: Bennett Brooks & Co Ltd
Chartered Accountants
Suite 1, First Floor
Coachworks Arcade
Northgate Street
Chester
Cheshire
CH1 2EY

Peslocus Healthcare Limited (Registered number: 09781184)

Balance Sheet
30 September 2024

2024 2023
Notes £ £
FIXED ASSETS
Tangible assets 4 957 1,178

CURRENT ASSETS
Debtors 5 62,501 71,421
Cash at bank 6,319 7,085
68,820 78,506
CREDITORS
Amounts falling due within one year 6 (20,641 ) (23,481 )
NET CURRENT ASSETS 48,179 55,025
TOTAL ASSETS LESS CURRENT LIABILITIES 49,136 56,203

CREDITORS
Amounts falling due after more than one year 7 (4,333 ) (8,333 )

PROVISIONS FOR LIABILITIES (239 ) (294 )
NET ASSETS 44,564 47,576

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 44,464 47,476
44,564 47,576

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 December 2024 and were signed on its behalf by:





Mr O Oyeleye - Director


Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements
for the year ended 30 September 2024

1. STATUTORY INFORMATION

Peslocus Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services provided in the period, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 2 ) .

Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Computer
equipment
£
COST
At 1 October 2023 4,273
Additions 97
At 30 September 2024 4,370
DEPRECIATION
At 1 October 2023 3,095
Charge for year 318
At 30 September 2024 3,413
NET BOOK VALUE
At 30 September 2024 957
At 30 September 2023 1,178

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Other debtors 62,501 71,421

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Bank loans and overdrafts 4,000 4,000
Taxation and social security 13,856 16,829
Other creditors 2,785 2,652
20,641 23,481

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£ £
Bank loans 4,333 8,333

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

2024 2023
£ £
Mr O Oyeleye and Mrs O Oyeleye
Balance outstanding at start of year 70,225 89,871
Amounts advanced 87,484 95,530
Amounts repaid (95,229 ) (115,176 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 62,480 70,225

Included within other debtors is £62,480 (2023 £70,225) owed to the company from both Mr O Oyeleye and Mrs O Oyeleye. The amount is unsecured, interest free and repayable on demand.

During the year dividends totalling £52,000 (2023 £90,000) were paid to the directors.

Peslocus Healthcare Limited (Registered number: 09781184)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

9. ULTIMATE CONTROLLING PARTY

During the year ended 30 September 2024 the directors Mr O and Mrs O Oyeleye, controlled the company by virtue of owning all of the issued share capital.

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Peslocus Healthcare Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Peslocus Healthcare Limited for the year ended 30 September 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Peslocus Healthcare Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Peslocus Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Peslocus Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Peslocus Healthcare Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Peslocus Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Peslocus Healthcare Limited. You consider that Peslocus Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Peslocus Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Bennett Brooks & Co Ltd
Chartered Accountants
Suite 1, First Floor
Coachworks Arcade
Northgate Street
Chester
Cheshire
CH1 2EY


20 December 2024